Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Company advancing dual clinical pathways, including a Samsung-supported PoC trial in Korea and a planned U.S. FDA trial with a leading California research university BELLEVUE, Wash., Dec. 20, 2025 /PRNewswire/ — OSR Holdings, Inc. (NASDAQ: OSRH) (“OSR Holdings”), a global healthcare holding company, today announced that the shareholders of Woori IO Co., Ltd. (“Woori IO”), a leading […]